Compared to CAR-T cells derived from healthy donors and lymphoma patients, CD8+ T effector cells from MG patients displayed compromised cytotoxicity, diminished proliferation signature, and significant mitochondrial dysfunction before infusion. The gene discussed is CD8A; the disease is myasthenia gravis.